WINDLAS

Windlas Biotech Ltd operates in the pharmaceutical and contract development and manufacturing organization (CDMO) industries. It functions as a CDMO specializing in manufacturing solid and liquid pharmaceutical dosage forms. Its product range includes oral solid formulations such as tablets, capsules, and sachets, complex generics, and health supplements. The company offers a broad spectrum of CDMO services encompassing product discovery, development, and commercial manufacturing of generic products. Windlas Biotech serves both domestic (India) and international business-to-business markets through its three main business segments: Generic Formulations CDMO, Trade Generics & Institutional, and Exports. No information on incorporation, founders, key management, subsidiaries, or listing exchanges is provided.